home.aspx
 
. https://pharmaceutical.report/Resources/Whitepapers/947b78b9-0181-4be6-a3d8-2e5acef73404_pm-corgenix-lab-eng-2019-04-15.pdf
infographic
SHARESHARESHARE
AROCELL AND CORGENIX ESTABLISH THE MEASUREMENT OF THYMIDINE
KINASE.
This collaboration will make AroCell’s patented biomarker assay available both as a service and as in the already existing AroCell TK 210 ELISA kit for measurements of TK1 protein concentrations in human serum samples. This will provide maximum flexibility for our customers in the USA. It also extends the services that Corgenix offers in their CAP compliant CLIA-lab (Clinical Laboratory Improvement Amendments-lab). Corgenix has over 25 years of experience in the In Vitro Diagnostic (IVD) industry focused on product development, manufacturing, regulation, distribution and contract services with a CAP/CLIA-lab based in Colorado, USA. A CAP/CLIA-lab is a clinical laboratory for human sample testing that follow CAP standards in USA.  DOWNLOAD